Home > Journals > European Journal of Physical and Rehabilitation Medicine > Past Issues > European Journal of Physical and Rehabilitation Medicine 2020 February;56(1) > European Journal of Physical and Rehabilitation Medicine 2020 February;56(1):68-72

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

 

ORIGINAL ARTICLE   Freefree

European Journal of Physical and Rehabilitation Medicine 2020 February;56(1):68-72

DOI: 10.23736/S1973-9087.19.05794-0

Copyright © 2019 EDIZIONI MINERVA MEDICA

language: English

Reduction in respiratory exacerbation rate in patients with severe bilateral cerebral palsy following daily PEP-mask therapy: a retrospective study

Chiara DI PEDE 1 , Elena COLOMBO 1, Miriam DUSO 2, Davide CONTE 1, Vittoria MARCON 1, Andrea VIANELLO 3, Stefano MASIERO 2, Andrea MARTINUZZI 1

1 Unit of Neurorehabilitation, IRCCS E. Medea Rehabilitation Hospital, Conegliano, Treviso, Italy; 2 Department of Neuroscience, University of Padua, Padua, Italy; 3 Division of Respiratory Pathophysiology and Intensive Care, University-City Hospital, Padua, Italy



BACKGROUND: Respiratory complications caused by the inability to protect the upper airways and ineffective cough represent a major cause of morbidity and mortality in patients with cerebral palsy (CP). Even though the application of positive end-expiratory pressure (PEP) through a face mask has gained large popularity as a technique to prevent bronchial mucous encumbrance, its long-term effects on clinical course and respiratory function in individuals with CP have not been investigated.
AIM: The aim of this study is to investigate whether regular application of PEP through a face mask can improve clinical status and respiratory function in patients with severe CP.
DESIGN: Observational, retrospective cohort study.
SETTING: The outpatient rehabilitation unit of the IRCCS E. Medea Rehabilitation Hospital in Conegliano, Italy.
POPULATION: CP outpatients admitted to the unit between January 1st, 2006 and December 31st, 2018.
METHODS: All the medical records of the enrolled patients were collected and reviewed. All patients underwent multidisciplinary respiratory evaluation at T0 (immediately before the beginning of PEP-use) and T1 (12 months after). The evaluation assessed respiratory infections history (number of exacerbations per year), blood gas analysis, measurement of airway resistance through the interrupter technique.
RESULTS: Twenty-one patients affected with CP (mean age 9.19±5.56 years, range 3-23 years, 8 females) were included. All patients had more than 3 infections per year (mean 4.81±1.17) in the year prior to treatment (T0). At T1 mean number of infections was 1.57±0.81); 17 patients (80%) reported less than three infections; two patients (10%) reported zero infections, two patients (10%) reported three infections. Blood gas analysis and airway resistance values did not show a significant difference at T0 and T1.
CONCLUSIONS: Daily PEP-mask therapy reduces frequency of respiratory exacerbations in patients with severe bilateral CP.
CLINICAL REHABILITATION IMPACT: PEP-mask is a valuable rehabilitative tool in severe CP patients with frequent respiratory exacerbations.


KEY WORDS: Positive-pressure respiration; Cerebral palsy; Respiratory tract infections

top of page